The following stocks are the leading risers and fallers on AIM in London on Monday.
AIM - WINNERS
Physiomics PLC, up 30% at 2.04 pence, 12-month range 0.9p-6.6p. The.
Physiomics PLC on Monday named Peter Sargent as its new chief operating officer.
Shares in Physiomics were up 21% at 1.90 pence each in London on Monday morning.
The mathematical modelling company.
Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Has been awarded a further contract by existing client Merck KGaA involving pre-clinical and.
Physiomics PLC on Thursday said it won its first contract with an unnamed UK-based biotech client.
The London-based mathematical modelling company that supports oncology drug development said the.
Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Says it has been awarded a further contract by its existing client, Numab Therapeutics. Numab.